Nutritional supplements that may be helpful: Sickle cell
anemia may result in vitamin B12 deficiency. A study of
children with sickle cell anemia found them to have a higher incidence of vitamin B12
deficiency than children without the disease.4 A study of 85 adults with sickle
cell anemia showed more of them had vitamin B12 deficiency than did a group of healthy
people.5 A subsequent preliminary trial demonstrated that for patients with low
blood levels of vitamin B12, intramuscular injections of 1 mg of vitamin B12 weekly for 12
weeks led to a significant reduction in symptoms.6 Researchers do not know whether
people with sickle cell anemia who are found to be deficient in vitamin B12 would benefit
equally from taking vitamin B12 supplements orally.
In a preliminary trial, 20 patients with sickle cell anemia were given either 1 mg of folic acid per day or folic acid plus 6 grams of aged garlic extract, 6 grams of vitamin C, and 1,200 mg of vitamin E
per day for six months.7 Patients taking the combination had a significant
improvement in their hematocrit (an index of anemia) and less painful crises than those taking
just folic acid.
Preliminary research has found that patients with sickle cell anemia are more likely to
have elevated blood levels of homocysteine
compared to healthy people.8 9 Elevated homocysteine is recognized as a
risk factor for cardiovascular
disease.10 In particular, high levels of homocysteine in sickle cell anemia
patients have been associated with a higher incidence of
stroke.11 Deficiencies of vitamin B6,
vitamin B12, and folic acid occur more frequently in people with sickle cell anemia than in
others12 13 14 and are a cause of high homocysteine
levels.15 A controlled trial found homocysteine levels were reduced 53% in children
with sickle cell anemia receiving a 2–4 mg supplement of folic acid per day, depending
on age, but vitamin B6 or B12 had no effect on homocysteine levels.16 A
double-blind trial of children with sickle cell anemia found that children given 5 mg of folic
acid per day had less painful swelling of the hands and feet compared with those receiving
placebo, but blood abnormalities and impaired growth rate associated with sickle cell anemia
were not improved.17 In the treatment of sickle cell anemia, folic acid is
typically supplemented in amounts of 1,000 mcg daily.18 Anyone taking this amount
of folic acid should have vitamin B12 status assessed by a healthcare professional.
Iron deficiency is relatively common in people
with sickle cell anemia, especially in pregnant women
and in children.19 20 Iron deficiency in people with sickle cell anemia
is best diagnosed with a laboratory test called serum ferritin.21 22
During sickle cell crises, however, serum ferritin is no longer useful as an indicator of iron
deficiency.23 The value of iron supplementation for
people with sickle cell anemia who are diagnosed with iron deficiency is unclear. Iron
supplements have, in some reports, reduced the severity of anemia as measured by laboratory
tests; however, some reports suggest they may increase the symptoms of sickle cell
anemia.24 25 Moreover, a state of iron deficiency has been shown to
reduce sickling of red blood cells in the blood of people with sickle cell
anemia.26 A small trial of iron restriction in patients with sickle cell
anemia found improvement in anemia and clinical symptoms as well as decreased red blood cell
breakdown during iron restriction.27 A doctor should be consulted before deciding
to supplement or restrict iron in sickle cell anemia.
Low concentrations of red blood cell magnesium have been noted in patients with sickle cell
anemia.28 29 Low magnesium, in turn, is thought to contribute to red
blood cell dehydration and a concomitant increase in symptoms. In a preliminary trial,
administration of 540 mg of magnesium per day for six
months to sickle cell anemia patients reversed some of the characteristic red blood cell
abnormalities and dramatically reduced the number of painful days for these
patients.30 The form of magnesium used in this trial, magnesium pidolate, is not
supplied by most magnesium supplements; it is unknown whether other forms of magnesium would
produce similar results.
In test tube studies, vitamin B6 has been shown to
have anti-sickling effects on the red blood cells of people with sickle cell
anemia.31 32 Vitamin B6 deficiency has been reported in some research to
be more common in people with sickle cell anemia than in healthy people.33
34 In a controlled trial, five sickle cell anemia patients with evidence of vitamin B6
deficiency were given 50 mg of vitamin B6 twice daily. The deficiency was reversed with this
supplement, but improvement in anemia was slight and considered insignificant.35
Therefore, evidence in support of vitamin B6 supplementation for people with sickle cell
anemia remains weak.
Antioxidant nutrients protect the body’s cells
from oxygen-related damage. Many studies show that sickle cell anemia patients tend to have
low blood levels of antioxidants, including carotenoids,
vitamin A, vitamin E,
and vitamin C, despite adequate intake.36
37 38 39 40 41 Low blood levels of vitamin E
in particular have been associated with higher numbers of diseased cells in
children42 and with greater frequency of symptoms in adults.43 A small,
preliminary trial reported a 44% decrease in the average number of diseased cells in six
sickle cell anemia patients given 450 IU vitamin E per day for up to 35 weeks. This effect was
maintained as long as supplementation continued.44
In another preliminary trial, 13 patients with sickle cell anemia were given two supplement
combinations for seven to eight months each. The first combination included 109 mg zinc, 153 IU vitamin E, 600 mg vitamin C, and 400 ml (about 14 ounces) of soybean oil
containing 11 grams of linoleic acid and 1.5 grams of alpha linolenic acid. The second
combination included 140 IU vitamin E, 600 mg vitamin C, and 20 grams of fish oil containing 6 grams of omega-3 fatty acids. Reduction in
diseased cells was observed only during the administration of the first protocol. The authors
concluded that zinc was the important difference between the two combinations and may be a
protector of red blood cell membranes.45
Fish oil alone has also been studied. In a double-blind trial, supplementation with
menhaden oil, in the amount of 250 mg per 2.2 pounds of body weight per day for one year,
reduced the frequency of severe pain episodes by approximately 45%, compared with
placebo.46
The zinc deficiency associated with sickle cell anemia appears to play a role in various
aspects of the illness. For example, preliminary research has correlated low zinc levels with
poor growth in children with sickle cell anemia.47 In a preliminary trial, 12
people with sickle cell anemia received 25 mg of zinc every four hours for 3 to 18
months.48 The number of damaged red blood cells fell from 28% to 18.6%. Addition of
2 mg of copper per day did not inhibit the effect of zinc. (Zinc supplementation in the
absence of copper supplementation induces a copper deficiency.) Patients with the highest
number of damaged red blood cells had a marked response to zinc, but those with lower levels
of damaged cells (less than 20% irreversibly sickled cells) had little or no response. Chronic
leg ulcers occur in about 75% of adults with sickle cell disease. In a controlled trial,
sickle cell patients with low blood levels of zinc received 88 mg of zinc three times per day
for 12 weeks.49 Ulcer healing rate was more than three times faster in the zinc
group than in the placebo group.
Are there any side effects or interactions? Refer to the individual supplement for
information about any side effects or interactions.
References:
1. Tangney CC, Phillips G, Bell RA, et al. Selected indices of
micronutrient status in adult patients with sickle cell anemia (SCA). Am J Hematol
1989;32:161–6.
2. Phillips G, Tangney CC. Relationship of plasma alpha tocopherol to
index of clinical severity in individuals with sickle cell anemia. Am J Hematol
1992;41:227–31.
3. Chiu D, Vichinsky E, Ho SL, et al. Vitamin C deficiency in patients
with sickle cell anemia. Am J Pediatr Hematol Oncol 1990;12:262–7.
4. Osifo BO, Adeyokunnu A, Parmentier Y, et al. Abnormalities of serum
transcobalamins in sickle cell disease (HbSS) in Black Africa. Scand J Haematol
1983;30:135–40.
5. al-Momen AK. Diminished vitamin B12 levels in patients with severe
sickle cell disease. J Intern Med 1995;237:551–5.
6. al-Momen AK. Diminished vitamin B12 levels in patients with severe
sickle cell disease. J Intern Med 1995;237:551–5.
7. Ohnishi ST, Ohnishi T, Ogunmola GB. Sickle cell anemia: A potential
nutritional approach for a molecular disease. Nutrition 2000;16:330–8.
8. van der Dijs FP, Schnog JJ, Brouwer DA, et al. Elevated homocysteine
levels indicate suboptimal folate status in pediatric sickle cell patients. Am J
Hematol 1998;59:192–8.
9. Houston PE, Rana S, Sekhasaria S, et al. Homocysteine in sickle cell
disease: relationship to stroke. Am J Med 1997;103:192–6.
10. Alpert MA. Homocysteine, atherosclerosis, and thrombosis. South
Med J 1999;92:858–65 [review].
11. Houston PE, Rana S, Sekhasaria S, et al. Homocysteine in sickle cell
disease: relationship to stroke. Am J Med 1997;103:192–6.
12. al-Momen AK. Diminished vitamin B12 levels in patients with severe
sickle cell disease. J Intern Med 1995;237:551–5.
13. Lin YK. Folic acid deficiency in sickle cell anemia. Scand J
Haematol 1975;14:71–9.
14. Natta CL, Reynolds RD. Apparent vitamin B6 deficiency in sickle cell
anemia. Am J Clin Nutr 1984;40:235–9.
15. Alpert MA. Homocysteine, atherosclerosis, and thrombosis. South
Med J 1999;92:858–65 [review].
16. van der Dijs FP, Schnog JJ, Brouwer DA, et al. Elevated homocysteine
levels indicate suboptimal folate status in pediatric sickle cell patients. Am J
Hematol 1998;59:192–8.
17. Rabb LM, Grandison Y, Mason K, et al. A trial of folate
supplementation in children with homozygous sickle cell disease. Br J Haematol
1983;54:589–94.
18. Waterbury L. Anemia. In Barker LR, Burton JR, Zieve PD.
Principles of ambulatory medicine, 4th ed. Baltimore: Williams & Wilkins, 1995,
605.
19. Pellegrini Braga JA, Kerbauy J, Fisberg M. Zinc, copper and iron and
their interrelations in the growth of sickle cell patients. Arch Latinoam Nutr
1995;45:198–203.
20. Reed JD, Redding-Lallinger R, Orringer EP. Nutrition and sickle cell
disease. Am J Hematol 1987;24:441–55 [review].
21. Vichinsky E, Kleman K, Embury S, Lubia B. The diagnosis of
iron-deficiency anemia in sickle cell disease. Blood 1981;58:963–8.
22. Rao KR, Patel AR, McGinnis P, Patel MK. Iron stores in adults with
sickle cell anemia. J Lab Clin Med 1984;103:792–7.
23. Brownell A, Lawson S, Bozovic M. Serum ferritin concentration in
sickle cell crisis. J Clin Pathol 1986;39:253–5.
24. Vichinsky E, Kleman K, Embury S, Lubia B. The diagnosis of
iron-deficiency anemia in sickle cell disease. Blood 1981;58:963–8.
25. Haddy TB, Castro O. Overt iron deficiency in sickle cell disease.
Arch Int Med 1982;142:1621–4.
26. Rao KR, Patel ER, Honig GR, et al. Iron deficiency and sickle cell
anemia. Arch Int Med 1983;143:1030–2.
27. Castro O, Poillon WN, Finkle H, Massac E. Improvement of sickle cell
anemia by iron-limited erythropoiesis. Am J Hematol 1994;47:74–81.
28. De Franceschi L, Bachir D, Galacteros F, et al. Oral magnesium
pidolate: effects of long-term administration in patients with sickle cell disease. Br J
Haematol 2000;108:284–9.
29. De Franceschi L, Bachir D, Balacteros F, et al. Oral magnesium
supplements reduce erythrocyte dehydration in patients with sickle cell disease. J Clin
Invest 1997;100:1847–52.
30. De Franceschi L, Bachir D, Galacteros F, et al. Oral magnesium
pidolate: effects of long-term administration in patients with sickle cell disease. Br J
Haematol 2000;108:284–9.
31. Kark JA, Kale MP, Tarassoff PG, et al. Inhibition of erythrocyte
sickling in vitro by pyridoxal. J Clin Invest 1978;62:888–91.
32. Kark JA, Tarassoff PG, Bongiovanni R. Pyridoxal phosphate as an
antisickling agent in vitro. J Clin Invest 1983;71:1224–9.
33. Flores L, Pais R, Buchanan I, et al. Pyridoxal 5’-phosphate
levels in children with sickle cell disease. Am J Pediatr Hematol Oncol
1988;10:236–40.
34. Reed JD, Redding-Lallinger R, Orringer EP. Nutrition and sickle cell
disease. Am J Hematol 1987;24:441–55.
35. Natta CL, Reynolds RD. Apparent vitamin B6 deficiency in sickle cell
anemia. Am J Clin Nutr 1984;40:235–9.
36. Tangney CC, Phillips G, Bell RA, et al. Selected indices of
micronutrient status in adult patients with sickle cell anemia (SCA). Am J Hematol
1989;32:161–6.
37. Chiu D, Vichinsky E, Ho SL, et al. Vitamin C deficiency in patients
with sickle cell anemia. Am J Pediatr Hematol Oncol 1990;12:262–7.
38. Jain SK, Ross JD, Duett J, Herbst JJ. Low plasma prealbumin and
carotenoid levels in sickle cell disease patients. Am J Med Sci
1990;229:13–5.
39. Jain SK, Williams DM. Reduced levels of plasma ascorbic acid (vitamin
C) in sickle cell disease patients: its possible role in the oxidant damage to sickle cells in
vitro. Clin Chim Acta 1985;149:257–61.
40. Natta C, Stacewicz-Sapuntzakis M, Bhagavan H, Bowen P. Low serum
levels of carotenoids in sickle cell anemia. Eur J Haematol 1988;41:131–5.
41. Essein, EU. Plasma levels of retinol, ascorbic acid and
alpha-tocopherol in sickle cell anemia. Centr Afr J Med 1995;41:48–50.
42. Ndombi IO, Kinoti SN. Serum vitamin E and the sickling status in
children with sickle cell anemia. East Afr Med J 1990;67:720–5.
43. Phillips G, Tangney CC. Relationship of plasma alpha tocopherol to
index of clinical severity in individuals with sickle cell anemia. Am J Hematol
1992;41:227–31.
44. Natta CL, Machlin LJ, Brin M. A decrease in irreversibly sickled
erythrocytes in sickle cell anemia patients given vitamin E. Am J Clin Nutr
1980;33:968–71.
45. Muskiet FA, Muskiet FD, Meiborg G, Schermer JG. Supplementation of
patients with homozygous sickle cell disease with zinc, alpha-tocopherol, vitamin C, soybean
oil, and fish oil. Am J Clin Nutr 1991;54:736–44.
46. Tomer A, Kasey S, Connor WE, et al. Reduction of pain episodes and
prothrombotic activity in sickle cell disease by dietary n-3 fatty acids. Thromb
Haemost 2001;85:966–74.
47. Pellegrini Braga JA, Kerbauy J, Fisberg M. Zinc, copper and iron and
their interrelations in the growth of sickle cell patients. Arch Latinoam Nutr
1995;45:198–203.
48. Brewer GJ, Brewer LF, Prasad AS. Suppression of irreversibly sickled
erythrocytes by zinc therapy in sickle cell anemia. J Lab Clin Med
1977;90:549–54.
49. Serjeant GR, Galloway RE, Gueri MC. Oral zinc sulphate in sickle-cell
ulcers. Lancet 1970;2:891–3.